Cargando…
A Case of Antiphospholipid Syndrome Refractory to Secondary Anticoagulating Prophylaxis after Deep Vein Thrombosis-Pulmonary Embolism
Antiphospholipid syndrome (APS) is an acquired systemic autoimmune disorder characterized by a combination of clinical criteria, including vascular thrombosis or pregnancy morbidity and elevated antiphospholipid antibody titers. It is one of the causes of deep vein thrombosis and pulmonary embolism...
Autores principales: | Gu, Kang Mo, Shin, Jong Wook, Park, In Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286787/ https://www.ncbi.nlm.nih.gov/pubmed/25580146 http://dx.doi.org/10.4046/trd.2014.77.6.274 |
Ejemplares similares
-
Anticoagulant Treatment of Deep Vein Thrombosis and Pulmonary Embolism: The Present State of the Art
por: Thaler, Johannes, et al.
Publicado: (2015) -
Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review
por: Mandernach, Molly W, et al.
Publicado: (2015) -
Pediatric Deep Venous Thrombosis and Pulmonary Embolism: Can It Be Antiphospholipid Syndrome?
por: Demir Yenigürbüz, Fatma, et al.
Publicado: (2019) -
Deep Vein Thrombosis in Lepromatous Leprosy: A Case Report of Secondary Pediatric Antiphospholipid Syndrome
por: Jones, Dyna, et al.
Publicado: (2022) -
Antiphospholipid antibodies in patients with upper-extremity deep vein thrombosis
por: Nikolova-Vlahova, Milena K., et al.
Publicado: (2015)